EASD 2023 - Miriam Cnop, Malin Fex and Timo Otonkoski on stem cell derived islets @EASDiabetes

Uploaded November 2023 | Updated September 2026, 3 days ago

Miriam Cnop, Malin Fex and Timo Otonkoski explained the current status on stem cell derived islets at EASD TV during #EASD2023. They described the progress being made in using stem cells as a disease model and how in the near future stem cell derived islets may be implanted as a treatment option for #type1diabetes.
#diabetes #t1d #stemcells #islets

EASD 2023 - Miriam Cnop, Malin Fex and Timo Otonkoski on stem cell derived islets

EASD 2025: SURPASS-CVOT - A Comparison of Tirzepatide and Dulaglutide

3rd EASD ECA Webinar: Tips & tricks to increase the chances of having your articles accepted

EASD 2024 - Will Next Generation Obesity Drugs make Bariatric Surgery Obsolete?

EASD 2025: EASD - ESC Joint Symposium: Hot Topics in Diabetes and Cardiovascular Disease

EASD 2024 - Breaking Barriers: Public-Private Partnerships Revolutionising Diabetes Research

6th EASD Early Career Academy Webinar: Best of EASD

#EASD2022 Interview with Helen Colhund and Andrew Paterson on cardiovascular disease and T1D

EASD 2023 - Andrew Frankel and Daniel van Raalte debating SGLT-2 inhibition for diabetes and CKD

Best of EASD 2025 by the EASD Early Career Academy - featuring Dr. Eugenia Martin-Vazquez

EASD 2023 - What have cohort studies taught us about the natural history of type 2 diabetes?

EASD 2024: The Sky is NOT the Limit! Ensuring Safe Travel for People Living with Diabetes